Jump to navigation Jump to search
|Commissioner of the Food and Drug Administration|
May 11, 2017 – April 5, 2019
|Preceded by||Robert Califf|
|Succeeded by||Norman Sharpless (acting)|
|Deputy Commissioner of Food and Drugs|
|President||George W. Bush|
|Education||Wesleyan University |
Mount Sinai School of Medicine
Gottlieb was a clinical assistant professor at New York University School of Medicine, a resident fellow at the conservative think tank the American Enterprise Institute, and an internist at Tisch Hospital.
References[change | change source]
- McGinley, Laurie; Bernstein, Lenny (March 5, 2019). "FDA Commissioner Gottlieb, who raised alarms about teen vaping, resigns". Washington Post. Retrieved March 5, 2019.
- LaMotte, Sandee (April 4, 2017). "Scott Gottlieb: Conflicts surround Trump's FDA pick". CNN. Retrieved 3 May 2017.
- Neel, Joe (March 10, 2017). "Trump To Nominate Dr. Scott Gottlieb To Head Food And Drug Administration". NPR. Retrieved March 10, 2017.
- Thomas, Katie, "F.D.A. Official Under Bush Is Said to Be Trump’s Choice to Lead Agency", New York Times, March 10, 2017. Retrieved 2017-03-10.
- Cunningham, Paige Winfield, "Trump expected to pick Scott Gottlieb to head FDA", Washington Examiner, March 10, 2017. Retrieved 2017-03-10.
- Dalzell, Michael D. (2011). "A Conversation With Scott Gottlieb, MD: The impact of health care reform on access to biologics, health policy, and managed care.". Biotechnology Healthcare 8 (3): 19–22. PMC 3278114. PMID 22479219.